biguanides has been researched along with Angiogenesis, Pathologic in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Narise, K | 1 |
| Okuda, K | 1 |
| Enomoto, Y | 1 |
| Hirayama, T | 1 |
| Nagasawa, H | 1 |
1 other study available for biguanides and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment.
Topics: Adaptation, Biological; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Biguanides; Cell Pr | 2014 |